Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT06350214
  4. Details
NCT06350214 Clinical Trial

Physical Activity and Nutrition in Cancer Survivors

Cancer Clinical Trial

Official title:
Joint Association of Physical Activity and Dietary Quality With Survival Among US Cancer Survivors

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06350214
Other study ID # #2005-06; #2011-17; #2018-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2007
Est. completion date December 31, 2018

Study information
Verified date April 2024
Source West China Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to investigate the independent and combined associations between physical activity and nutrition condition with mortality among cancer survivors.

Recruitment information / eligibility
Status Completed
Enrollment 3100
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants with history of cancers were included Exclusion Criteria: - Participants with missing cancer investigation, dietary recall, and incomplete follow-up information were excluded from this study.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• physical activity and nutrition assessment
Assessment of the physical activity and nutrition condition of cancer survivors.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
West China Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary All-cause mortality To evaluate the overall survival of cancer survivors Jan 1 2017 to Dec 31 2019
Primary Cause-specific mortality To evaluate the cancer specific survival of cancer survivors Jan 1 2017 to Dec 31 2019
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases